Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Make your voice heard: Call for input on AI, the UPC, and patent trends
Europe
Survey launched ahead of LSIPR’s LSPN Europe conference | Seeks input on AI impact, Brexit, and Unitary Patent system | Focuses on patent challenges in pharma, biotech, medical devices, diagnostics to shape conference discussions in London.   4 June 2025
J&J unit could owe biotech $125m over AI-based surgical ‘night vision’ tech
Americas
New York court finds Ethicon breached agreement with ChemImage over advanced imaging technologies | Parties dispute damages for IP ‘impairment’.   3 June 2025
FisherBroyles appoints biotech-focused partner in DC
Careers
The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular biology and medical technologies.   3 June 2025
Americas
The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation services, bringing together 50 professionals and expanding into Boston.   3 June 2025
Europe
A new law affecting disputes concerning the ‘Bolar provision’ could allow competitors to enter the Ukrainian market before a patent expires, explains Volodymyr Hrunskyi of Sayenko Kharenko.   3 June 2025
Americas
The seasoned patent litigators join from Mayer Brown, bringing decades of high-stakes experience in pharma and biotech patent disputes, including work on Hatch-Waxman and biosimilar litigation.   2 June 2025
Americas
Novo Nordisk faces resistance from Connecticut clinic in Ozempic and Wegovy dispute | LIVation admits to referencing Novo Nordisk products in past marketing but it has since been removed | Clinic claims its compounded semaglutide use was lawful and clear to patients.   29 May 2025
Americas
Shilpa Medicare failed to prove invalidity of patent covering Lenvima | Eisai says ruling keeps India-based generic maker’s product off the market until 2036.   29 May 2025
Americas
Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic company hoped to stay proceedings to prepare appeal against unfavourable decision.   27 May 2025
Europe
UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories.   27 May 2025